Latest filing published 26 Apr 2021 for Lixte Biotechnology Holdings, INC., €45k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Philip F. Palmedo: trading record in brief
Philip F. Palmedo is a declared insider of Lixte Biotechnology Holdings, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 7 December 2018 to 22 April 2021.
Purchases make up the whole of the open-market record (2 purchases, €127k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise.
Most recently, on 26 April 2021, the filings show an option exercise worth €45k in Lixte Biotechnology Holdings, Inc. The last purchase on record was published on 3 December 2020, which is 2,167 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Philip F. Palmedo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75,000 shares@ US$0.7226.1% of flowCommon StockSEC:0001493152-21-009687:0
- 21,053 shares@ US$4.75100.0% of flowCommon StockSEC:0001493152-20-022869:0Canonical exit: 28 Feb 2021 (T+90)
- 100,000 shares@ US$0.5034.5% of flowCommon StockSEC:0001250853-18-000152:0Canonical exit: 7 Mar 2019 (T+90)
3 of 3 declarations
